Life AI Net
Home
Archive
Calculators
Directory
Newsletter
Login
English
English
简体中文
Deutsch
Français
Español
日本語
한국어
العربية
Auto
Home
Archive
Calculators
Directory
Newsletter
English
简体中文
Deutsch
Français
Español
日本語
한국어
العربية
Auto
Login
Home
Archive
Calculators
Directory
More
Live
Endpoints News
UK waitlist for Novo's Wegovy pill triples in week after approval, major online pharmacy says
Endpoints News
Hackers claim they stole Novo Nordisk AI models, manufacturing recipes
Endpoints News
In second reversal, FDA gives uniQure a green light to seek accelerated approval
BioPharma Dive
Jazz zeroes in on next-gen T cell engagers with AbCellera deal
Clinical OMICs
Vibrating Pill Predicts Anorexia Relapse
FierceBiotech
Vedana Therapeutics surfaces with $46M to develop next generation of migraine prevention therapies
FierceBiotech
UniQure stock surges after FDA U-turn clears path to gene therapy filing
PharmaVoice
Why ivermectin is in the limelight again
Clinical OMICs
Philippe Pouletty: Turning Europe’s Life Science Startups Into World Leaders
BioWorld
Lundbeck patents new orexin OX2 receptor agonists
BioWorld
Zealand Pharma reports IL-23R antagonists
BioWorld
Chengdu Chipscreen Pharmaceutical synthesizes new MOGAT2 inhibitors
Endpoints News
UK waitlist for Novo's Wegovy pill triples in week after approval, major online pharmacy says
Endpoints News
Hackers claim they stole Novo Nordisk AI models, manufacturing recipes
Endpoints News
In second reversal, FDA gives uniQure a green light to seek accelerated approval
BioPharma Dive
Jazz zeroes in on next-gen T cell engagers with AbCellera deal
Clinical OMICs
Vibrating Pill Predicts Anorexia Relapse
FierceBiotech
Vedana Therapeutics surfaces with $46M to develop next generation of migraine prevention therapies
FierceBiotech
UniQure stock surges after FDA U-turn clears path to gene therapy filing
PharmaVoice
Why ivermectin is in the limelight again
Clinical OMICs
Philippe Pouletty: Turning Europe’s Life Science Startups Into World Leaders
BioWorld
Lundbeck patents new orexin OX2 receptor agonists
BioWorld
Zealand Pharma reports IL-23R antagonists
BioWorld
Chengdu Chipscreen Pharmaceutical synthesizes new MOGAT2 inhibitors
Archive
This story is not available in the archive.